Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

Long GV, Pires da Silva I, Perry KA, Romano J, Lo SN, Grover P, Ascierto PA, Amaria RN, Hieken TJ, Robert C, Heinzerling L, Sandhu S, Barros M, Mitchell TC, Eroglu Z, Samoylenko IV, Flatz L, Lebbé C, Johnson DB, Rutkowski P, Muñoz-Couselo E, Hamid O, Trojaniello C, Mallardo D, Block MS, Hammoudi N, Benannoune N, Tomsitz D, Wang Y, Dinckal C, Kuzmenko A, Forschner A, Carlino MS, Jalving M, Postow MA, Ferrucci PF, Kapiteijn E, van der Veldt AAM, Suijkerbuijk KPM, da Meda L, Burnette H, Czarnekca A, Mehmi I, Hospers G, Lochrin S, van Akkooi ACJ, Tawbi HA, Burton EM, Tetzlaff MT, Wiel BAV, Rawson RV, Blank CU, Menzies AM

Open source

DOI
10.1038/s41591-026-04677-z
Published
2026 Oct 1
Container
Nature medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04677-z,
  title = {Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).},
  author = {Long GV and Pires da Silva I and Perry KA and Romano J and Lo SN and Grover P and Ascierto PA and Amaria RN and Hieken TJ and Robert C and Heinzerling L and Sandhu S and Barros M and Mitchell TC and Eroglu Z and Samoylenko IV and Flatz L and Lebbé C and Johnson DB and Rutkowski P and Muñoz-Couselo E and Hamid O and Trojaniello C and Mallardo D and Block MS and Hammoudi N and Benannoune N and Tomsitz D and Wang Y and Dinckal C and Kuzmenko A and Forschner A and Carlino MS and Jalving M and Postow MA and Ferrucci PF and Kapiteijn E and van der Veldt AAM and Suijkerbuijk KPM and da Meda L and Burnette H and Czarnekca A and Mehmi I and Hospers G and Lochrin S and van Akkooi ACJ and Tawbi HA and Burton EM and Tetzlaff MT and Wiel BAV and Rawson RV and Blank CU and Menzies AM},
  year = {2026},
  journal = {Nature medicine},
  doi = {10.1038/s41591-026-04677-z},
  url = {https://doi.org/10.1038/s41591-026-04677-z}
}

RIS

TY  - JOUR
TI  - Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
AU  - Long GV
AU  - Pires da Silva I
AU  - Perry KA
AU  - Romano J
AU  - Lo SN
AU  - Grover P
AU  - Ascierto PA
AU  - Amaria RN
AU  - Hieken TJ
AU  - Robert C
AU  - Heinzerling L
AU  - Sandhu S
AU  - Barros M
AU  - Mitchell TC
AU  - Eroglu Z
AU  - Samoylenko IV
AU  - Flatz L
AU  - Lebbé C
AU  - Johnson DB
AU  - Rutkowski P
AU  - Muñoz-Couselo E
AU  - Hamid O
AU  - Trojaniello C
AU  - Mallardo D
AU  - Block MS
AU  - Hammoudi N
AU  - Benannoune N
AU  - Tomsitz D
AU  - Wang Y
AU  - Dinckal C
AU  - Kuzmenko A
AU  - Forschner A
AU  - Carlino MS
AU  - Jalving M
AU  - Postow MA
AU  - Ferrucci PF
AU  - Kapiteijn E
AU  - van der Veldt AAM
AU  - Suijkerbuijk KPM
AU  - da Meda L
AU  - Burnette H
AU  - Czarnekca A
AU  - Mehmi I
AU  - Hospers G
AU  - Lochrin S
AU  - van Akkooi ACJ
AU  - Tawbi HA
AU  - Burton EM
AU  - Tetzlaff MT
AU  - Wiel BAV
AU  - Rawson RV
AU  - Blank CU
AU  - Menzies AM
PY  - 2026
JO  - Nature medicine
DO  - 10.1038/s41591-026-04677-z
UR  - https://doi.org/10.1038/s41591-026-04677-z
ER  -

APA

GV, L., I, P. D. S., KA, P., J, R., SN, L., P, G., PA, A., RN, A., TJ, H., C, R., L, H., S, S., M, B., TC, M., Z, E., IV, S., L, F., C, L., DB, J., P, R., E, M., O, H., C, T., D, M., MS, B., N, H., N, B., D, T., Y, W., C, D., A, K., A, F., MS, C., M, J., MA, P., PF, F., E, K., AAM, V. D. V., KPM, S., L, D. M., H, B., A, C., I, M., G, H., S, L., ACJ, V. A., HA, T., EM, B., MT, T., BAV, W., RV, R., CU, B., & AM, M. (2026). Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).. Nature medicine. https://doi.org/10.1038/s41591-026-04677-z

Source records